.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Scientists have identified common molecular pathways in IgA nephropathy and celiac disease. Both conditions involve dysregulated immune responses and IgA deposits. However, the exact genetic link remained a mystery for years. Recent research now highlights a strong gut-kidney axis. This connection suggests that intestinal inflammation directly impacts kidney health. Consequently, clinicians must consider the presence of both disorders in symptomatic patients.
The study utilized transcriptomic analysis and machine learning to find shared hub genes. Researchers pinpointed ITGB2, CD74, and KLK1 as the primary biomarkers. Specifically, these three genes demonstrate exceptional diagnostic accuracy. A combined model using these markers achieved an area under the curve (AUC) of 0.9. Furthermore, single-cell RNA sequencing confirmed their specific roles in immune cells. These genes contribute to disease progression and immune dysregulation in both IgA nephropathy and celiac disease.
In addition to diagnostics, the research predicted four candidate therapeutic agents. These drugs might offer new ways to stabilize the immune system. Collectively, these findings provide fresh insights into pathogenesis. They also suggest that targeted therapies could treat both conditions simultaneously.
While celiac disease does not directly cause IgA nephropathy, they share similar immune triggers. Patients with celiac disease have a higher risk of developing IgA deposits in the kidneys due to the gut-kidney axis.
The biomarkers ITGB2, CD74, and KLK1 help doctors diagnose both conditions more accurately. They also provide potential targets for future drug development.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers identify ITGB2, CD74, and KLK1 as shared hub genes for IgA nephropathy and celiac disease, providing new diagnostic and therapeutic insights....
8 months ago
Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today
A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today
The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today
Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
